PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z))

Term ID

CHEBI:89296

Synonyms

1-(10Z,13Z,16Z-Docosatrienoyl)-2-(6Z,9Z,12Z-octadecatrienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-(10Z,13Z,16Z-Docosatrienoyl)-2-g-linolenoyl-sn-glycero-3-phosphoinositol
1-(10Z,13Z,16Z-Docosatrienoyl)-2-gamma-linolenoyl-sn-glycero-3-phosphoinositol
[(2R)-3-[(10Z,13Z,16Z)-docosa-10,13,16-trienoyloxy]-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(22:3/18:3)
Phosphatidylinositol(22:3n6/18:3n6)
Phosphatidylinositol(22:3w6/18:3w6)
Phosphatidylinositol(40:6)
PI(22:3/18:3)
PI(22:3n6/18:3n6)
PI(22:3w6/18:3w6)
PI(40:6)
PIno(22:3/18:3)
PIno(22:3n6/18:3n6)
PIno(22:3w6/18:3w6)
PIno(40:6)

(all 16)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z))

Phenotype where environments contain PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z))

Phenotype modified by environments containing PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z))

Phenotype affecting PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z))

Human Disease Model